~~<i id='CABC79F8A5'><strike id='CABC79F8A5'><tt id='CABC79F8A5'><pre id='CABC79F8A5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

leisure time

author：knowledge 2025-10-02 06:02:22 - browse：4

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Change Healthcare cyberattack shows risk of industry consolidation

explore

Wikipedia

leisure time

explore

focus

JUSTINTALLIS/AFPviaGettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup toge

WSS

'Vaccine

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

Neuroscience renaissance leads to new crop of psychiatric drugs

Drinking water from half of US faucets contains PFAS: Study

US intelligence assessment says Iran not currently developing nuclear weapons

Using force crossed my mind when examining a defiant young patient

Wikipedia

leisure time

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

UPS workers' union leader explains what's at stake as strike edges closer

State Dept. review finds Biden bears some blame for Afghanistan failures

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

Affirmative action in medical school literally saved lives

Color Health wants to make cancer screenings convenient

As demand for Covid shots wanes, Moderna seeks its next success

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

Activists slam private health insurers over coverage restrictions

Using force crossed my mind when examining a defiant young patient

explore

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

FDA approves Leqembi, a milestone in Alzheimer’s treatment

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

Children’s Hospital revives plan for pedestrian bridge

How corporate America is slashing DEI workers amid backlash to diversity programs

Redefining sustainability for the pharmaceutical industry

Wikipedia

leisure time

explore

focus